SOL-GEL TECHNOLOGIES LTD
SOL-GEL TECHNOLOGIES LTD logo
SLGL

SOL-GEL TECHNOLOGIES LTD (SLGL)

$4.552.15%

Market is closed
– opens on 8 PM, 12 Dec 2022
  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

$4.55
Day's Range
$4.59
$3.94
52-Week Range
$8.51
1 month return6.95%
3 month return21.55%
1 year return41.29%
5 year return66.64%

Company Information

Sol-Gel is a clinical-stage dermatology company focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. Sol-Gel leverages its proprietary microencapsulation technology platform for the development of Twyneo, under investigation for the treatment of acne vulgaris, and Epsolay, under investigation for the treatment of inflammatory lesions of rosacea. The Company's pipeline also includes SGT-210 (erlotinib gel), under investigation for the treatment of palmoplantar keratoderma, and three pre-clinical assets - erlotinib, tapinarof and roflumilast - currently being tested for various pharmaceutical indications.
OrganizationSOL-GEL TECHNOLOGIES LTD
Employees53
CEODr. Alon Seri-Levy
IndustryHealth Technology

Analyst Recommendation

based on 4 analysts ratings

Buy
100%
Buy
0%
Hold
0%
Sell

Based on 4 Wall street analysts offering stock ratings for SOL-GEL TECHNOLOGIES LTD(by analysts ranked 0 to 5 stars)

Analyst Forecast

What analysts predicted

Upside of 174.73%

Current

$4.55

Target

$12.5

Recommendation Trend

Based on 4 analyst

Current1M Ago3M Ago
Buy
4
7
8
Hold
0
1
1
Sell
0
0
0
Consensus
BUY
BUY
BUY

Company Financials

  • Annual
  • Quarterly

Highlights

Market Capitalization
107.6M
Book Value
$2.05
Dividend Share
0.0
Dividend Yield
0.0%
Earnings Per Share (EPS)
0.21
PE Ratio
22.14
Wall Street Target Price
12.5

Valuation

Trailing PE22.14
Forward PE9.34
Price/Book (mrq)
2.22
Enterprise Value
70.8M
Enterprise Value/Revenue
2.88
Enterprise Value/Ebitda
18.07

Technicals

Beta
1.3
50 Day MA
4.86
200 Day MA
5.8

Institutional Holdings

Phoenix Holdings Ltd

11.13%

Migdal Insurance & Financial Holdings Ltd

5.32%

Harel Insurance Invests & Fin Srvcs Ltd

3.98%

Kingdon Capital Management LLC

3.6%

Raymond James Finl Svs Advisors, Inc.

0.27%

Raymond James & Associates

0.19%

Discover more

Frequently Asked Questions

What is SOL-GEL TECHNOLOGIES LTD share price today?

Can Indians buy SOL-GEL TECHNOLOGIES LTD shares?

How can I buy SOL-GEL TECHNOLOGIES LTD shares from India?

Can Fractional shares of SOL-GEL TECHNOLOGIES LTD be purchased?

What are the documents required to start investing in SOL-GEL TECHNOLOGIES LTD stocks?

What are today’s High and Low prices of SOL-GEL TECHNOLOGIES LTD?

What are today’s traded volumes of SOL-GEL TECHNOLOGIES LTD?

What is today’s market capitalisation of SOL-GEL TECHNOLOGIES LTD?

What is the 52 Week High and Low Range of SOL-GEL TECHNOLOGIES LTD?

How much percentage SOL-GEL TECHNOLOGIES LTD is down from its 52 Week High?

How much percentage SOL-GEL TECHNOLOGIES LTD is up from its 52 Week low?

What are the historical returns of SOL-GEL TECHNOLOGIES LTD?

Who is the Chief Executive Officer (CEO) of SOL-GEL TECHNOLOGIES LTD?

Trading and brokerage services provided by

Banking and Remittance services provided by

Technology services provided by : Finzoomers Services Private Limited

Disclaimer: These services are not for exchange traded products.The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Finzoomers Services Private Limited acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*